Expanding Prevalence Of Cardiovascular And Peripheral Diseases Fuels Drug-Eluting Balloon Catheter Market Growth: Key Factor Driving The Growth In The Drug Eluting Balloons Catheters Market

The Drug Eluting Balloons Catheters Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Drug Eluting Balloons Catheters Market Size During the Forecast Period?
In the past few years, there has been a significant expansion in the size of the drug-eluting balloons catheters market. The market is projected to increase from $1.43 billion in 2024 to $1.66 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 16.0%. Several factors contribute to this growth during the historical period such as the rise in respiratory disorders, the superiority of these devices over traditional inhalers, patients' inclination towards DPIs, governmental health initiatives in respiratory health, strategic collaborations and partnerships, advancements in drug formulations, and an increasing elderly population.

The market for drug eluting balloons catheters is predicted to experience significant growth in the coming years, soaring to a worth of $2.61 billion in 2029 with a compound annual growth rate (CAGR) of 12.0%. This projected growth during the forecast period is primarily attributed to the continuous rise in respiratory disorders, growth of the elderly population, enhanced awareness and education, market development in emerging economies, tailored drug formulations, regulatory support and adherence, as well as innovations in packaging and design. The forecast period will also witness certain trends including the use of smart inhalers and connectivity, a shift towards breath-actuated inhalers, emphasis on pediatric and geriatric patient needs, delivery of biologics, and eco-friendly inhaler designs.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13429

What Are the High-Growth Segments in the Drug Eluting Balloons Catheters Market?
The drug eluting balloons catheters market covered in this report is segmented -

1) By Product: Coronary Artery Disease Drug-Eluting Balloon Catheters, Peripheral Vascular Disease Drug-Eluting Balloon Catheters
2) By Drug: Paclitaxel, Sirolimus, Other Drugs
3) By Raw Material: Nylon, Polyurethane, Other Raw Materials
4) By End-User: Hospitals And Clinics, Ambulatory Surgical Centers, Catheterization Laboratories

Subsegments:
1) By Coronary Artery Disease: Drug-Eluting Balloon Catheters, Plain Balloon Catheters
2) By Peripheral Vascular Disease: Drug-Eluting Balloon Catheters, Angioplasty Balloon Catheters
3) By Angioplasty Balloon Catheters: Drug-Eluting Angioplasty Balloon Catheters

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13429&type=smp

What Key Drivers Are Expected to Influence Future Drug Eluting Balloons Catheters Market Growth?
The drug-eluting balloon catheter market is anticipated to expand due to the rising incidence of peripheral and cardiovascular diseases. Cardiovascular diseases, a set of conditions that affect the heart and circulatory system, along with peripheral artery disease, which inhibits blood flow mainly to the arms or legs due to narrowed arteries, are notable factors contributing to market growth. Drug-eluting balloon catheters, which treat coronary artery disease through a semi-compliant angioplasty balloon coated with an anti-proliferative substance, have an anti-restenotic effect once they enter the vessel. For instance, as reported by the US-based government agency, the Centers for Disease Control and Prevention, heart disease led to 702,880 deaths, representing one out of every five deaths in 2022. Furthermore, about 805,000 people in the United States suffer a heart attack each year, with 605,000 experiencing their first one and 200,000 having had previous ones. Therefore, the increasing incidence of peripheral and cardiovascular diseases is a significant driver of the drug-eluting balloon catheter market. Market Driver in Drug Eluting Balloons Catheters: Accelerated Growth from Minimally Invasive Procedures Demand

Which Companies Hold the Largest Share Across Different Drug Eluting Balloons Catheters Market Segments?
Major companies operating in the drug eluting balloons catheters market report are Abbott Laboratories, Medtronic PLC, Becton Dickinson and Company, Koninklijke Philips NV, Boston Scientific Corporation, B Braun Melsungen Aktiengesellschaft, Terumo Corporation, Cook Medical LLC, Lepu Medical Technology Co. Ltd., Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, BIOTRONIK SE & Co. KG, Acotec Scientific Co. Ltd., Cordis Corporation, Biosensors International Group Ltd., Zylox-Tonbridge Medical Technology Co. Ltd., Mermaid Medical AS, Hexacath Limited, Zhejiang Barty Medical Technology Co. Ltd., Cardionovum GmbH, Nano Therapeutics Pvt. Ltd., Tokai Medical Products Inc., Opto Circuits Limited, Acrostak (Schweiz) AG, Machine Solutions Inc., Concept Medical Inc., Aachen Resonance GmbH, AR Baltic Medical UAB

What Trends Are Driving Growth in The Drug Eluting Balloons Catheters Market?
Leading entities in the drug-eluting balloon catheter market are shifting their focus towards the creation of state-of-the-art products using cutting-edge technology to establish a competitive advantage. For example, in March 2024, Boston Scientific Corporation, a multinational medical device manufacturer based in the US, revealed that it had received approval from the U.S. Food and Drug Administration (FDA) for its AGENT Drug-Coated Balloon (DCB). This is the first coronary balloon coated with drugs available in the U.S for the treatment of in-stent restenosis (ISR), which is a condition where a stented vessel is blocked by plaque or scar tissue. The balloon is coated with paclitaxel, which helps decrease the recurrence of ISR by delivering a therapeutic dose to the vessel wall, without the need for more stents or radiation. Clinical studies showed a reduction in heart attack risk at the target location by 49% and recorded minimal adverse event rates.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/drug-eluting-balloons-catheters-global-market-report

What Are the Emerging Geographies for The Drug Eluting Balloons Catheters Market Growth?
North America was the largest region in the drug eluting balloons catheters market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the drug eluting balloons catheters market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Drug Eluting Balloons Catheters Market?
2. What is the CAGR expected in the Drug Eluting Balloons Catheters Market?
3. What Are the Key Innovations Transforming the Drug Eluting Balloons Catheters Industry?
4. Which Region Is Leading the Drug Eluting Balloons Catheters Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.